Neurogene (NGNE) News Today $17.51 +0.42 (+2.46%) As of 02:51 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NGNE Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Deutsche Bank AG Sells 181,997 Shares of Neurogene Inc. (NASDAQ:NGNE)Deutsche Bank AG cut its stake in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) by 54.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 152,371 shares of the company's stock after selling 181,997 shares during the period. Deutsche Bank AG ownedMay 23, 2025 | marketbeat.comNeurogene (NASDAQ:NGNE) Stock Price Expected to Rise, BMO Capital Markets Analyst SaysMay 23, 2025 | americanbankingnews.com80,000 Shares in Neurogene Inc. (NASDAQ:NGNE) Bought by Vestal Point Capital LPVestal Point Capital LP acquired a new position in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 80,000 shares of the company's stock, valued at approximately $1,829,0May 21, 2025 | marketbeat.comRaiffeisen Bank International AG Makes New Investment in Neurogene Inc. (NASDAQ:NGNE)Raiffeisen Bank International AG acquired a new stake in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 16,000 shares of the company's stock, valuMay 20, 2025 | marketbeat.comThe Manufacturers Life Insurance Company Invests $322,000 in Neurogene Inc. (NASDAQ:NGNE)The Manufacturers Life Insurance Company purchased a new stake in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 14,079 shares of the company's stock, valued at approximately $322,000. The ManufactMay 20, 2025 | marketbeat.comNeurogene (NASDAQ:NGNE) Stock Rating Lowered by Baird R WBaird R W lowered Neurogene from a "strong-buy" rating to a "hold" rating in a research report on Friday.May 19, 2025 | marketbeat.comNeurogene Inc. (NASDAQ:NGNE) Receives $46.20 Average Price Target from BrokeragesMay 19, 2025 | americanbankingnews.comRTW Investments LP Purchases 215,000 Shares of Neurogene Inc. (NASDAQ:NGNE)RTW Investments LP increased its position in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) by 18.9% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,350,256 shares of the company's stock after buying an additionalMay 18, 2025 | marketbeat.comNeurogene (NASDAQ:NGNE) Cut to "Neutral" at Robert W. BairdMay 18, 2025 | americanbankingnews.comNeurogene (NASDAQ:NGNE) Rating Lowered to "Hold" at Baird R WMay 18, 2025 | americanbankingnews.comBaird Downgrades Neurogene (NGNE)May 16, 2025 | msn.comNeurogene Announces Evidence-Based Monitoring and Treatment Intended to Reverse Rare Hyperinflammatory Syndrome Associated with High-Dose AAVMay 16, 2025 | finance.yahoo.comStuart Cobb Sells 6,797 Shares of Neurogene Inc. (NASDAQ:NGNE) StockMay 16, 2025 | insidertrades.comOCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $748,000 Position in Neurogene Inc. (NASDAQ:NGNE)OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) by 270.8% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 32,734 shares of the company's stock after purchasMay 16, 2025 | marketbeat.comNeurogene Inc. (NASDAQ:NGNE) Given Average Recommendation of "Buy" by AnalystsNeurogene Inc. (NASDAQ:NGNE - Get Free Report) has been assigned an average rating of "Buy" from the seven brokerages that are covering the firm, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the compMay 16, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Sells 23,477 Shares of Neurogene Inc. (NASDAQ:NGNE)Schonfeld Strategic Advisors LLC lowered its holdings in Neurogene Inc. (NASDAQ:NGNE - Free Report) by 71.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 9,189 shares of the company's stock after selling 2May 16, 2025 | marketbeat.comNeurogene (NASDAQ:NGNE) Given New $45.00 Price Target at HC WainwrightHC Wainwright dropped their price objective on shares of Neurogene from $50.00 to $45.00 and set a "buy" rating on the stock in a research report on Tuesday.May 15, 2025 | marketbeat.comOctagon Capital Advisors LP Increases Stake in Neurogene Inc. (NASDAQ:NGNE)Octagon Capital Advisors LP increased its stake in Neurogene Inc. (NASDAQ:NGNE - Free Report) by 1,920.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 303,000 shares of the comMay 15, 2025 | marketbeat.comDriehaus Capital Management LLC Sells 69,422 Shares of Neurogene Inc. (NASDAQ:NGNE)Driehaus Capital Management LLC decreased its position in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) by 67.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 32,765 shares of the company's stock after selling 6May 13, 2025 | marketbeat.comNeurogene (NASDAQ:NGNE) Posts Quarterly Earnings Results, Misses Estimates By $0.03 EPSNeurogene (NASDAQ:NGNE - Get Free Report) posted its quarterly earnings results on Friday. The company reported ($1.08) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.05) by ($0.03).May 13, 2025 | marketbeat.comDAFNA Capital Management LLC Has $1.18 Million Position in Neurogene Inc. (NASDAQ:NGNE)DAFNA Capital Management LLC grew its position in Neurogene Inc. (NASDAQ:NGNE - Free Report) by 562.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 51,500 shares of the company's stock after purchasing an additionalMay 10, 2025 | marketbeat.comDeerfield Management Company L.P. Series C Makes New Investment in Neurogene Inc. (NASDAQ:NGNE)Deerfield Management Company L.P. Series C acquired a new stake in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 448,145 shares of the company's stock, valued at apMay 10, 2025 | marketbeat.comNeurogene Reports First Quarter 2025 Financial Results and Highlights Recent UpdatesMay 9, 2025 | businesswire.comNeurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 8, 2025 | businesswire.comCasdin Capital LLC Grows Stake in Neurogene Inc. (NASDAQ:NGNE)Casdin Capital LLC lifted its stake in Neurogene Inc. (NASDAQ:NGNE - Free Report) by 146.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,295,361 shares of the company's stock after purchasing an additiMay 8, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Invests $2.82 Million in Neurogene Inc. (NASDAQ:NGNE)Price T Rowe Associates Inc. MD acquired a new stake in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 123,291 shares of the company's stock, valued at approximaMay 8, 2025 | marketbeat.comBaker BROS. Advisors LP Boosts Holdings in Neurogene Inc. (NASDAQ:NGNE)Baker BROS. Advisors LP grew its position in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) by 47.9% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 674,450 shares of the company's stock after buying an additional 218,435 shares durinMay 6, 2025 | marketbeat.comArrowMark Colorado Holdings LLC Has $10.26 Million Stock Position in Neurogene Inc. (NASDAQ:NGNE)ArrowMark Colorado Holdings LLC grew its position in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) by 16.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 448,601 shares of the company's stock after acquiring aMay 6, 2025 | marketbeat.comNeurogene (NGNE) Expected to Announce Earnings on FridayNeurogene (NASDAQ:NGNE) will be releasing its Q1 2025 earnings before the market opens on Friday, May 9. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-9-neurogene-inc-stock/)May 4, 2025 | marketbeat.comSamsara BioCapital LLC Acquires 449,337 Shares of Neurogene Inc. (NASDAQ:NGNE)Samsara BioCapital LLC lifted its stake in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) by 35.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,717,127 shares of the company's stock after buying an additional 449,337 sharesMay 2, 2025 | marketbeat.comNeurogene Announces Upcoming Oral Presentation on Monitoring and Treatment to Reverse Rare Complication of High Dose Gene Therapy at the ASGCT Annual MeetingApril 28, 2025 | businesswire.comRock Springs Capital Management LP Invests $2.18 Million in Neurogene Inc. (NASDAQ:NGNE)Rock Springs Capital Management LP bought a new position in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 95,407 shares of the company's stock, valApril 23, 2025 | marketbeat.comNeurogene Inc. (NASDAQ:NGNE) Shares Bought by Walleye Capital LLCWalleye Capital LLC grew its position in Neurogene Inc. (NASDAQ:NGNE - Free Report) by 68.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 74,836 shares of the company's stock after buying an additiApril 22, 2025 | marketbeat.comNeurogene Inc. (NASDAQ:NGNE) Given Average Rating of "Buy" by BrokeragesShares of Neurogene Inc. (NASDAQ:NGNE - Get Free Report) have been given a consensus recommendation of "Buy" by the eight analysts that are presently covering the company, Marketbeat reports. Seven investment analysts have rated the stock with a buy rating and one has issued a strong buy rating oApril 21, 2025 | marketbeat.comBMO Capital Markets Has Lowered Expectations for Neurogene (NASDAQ:NGNE) Stock PriceBMO Capital Markets dropped their target price on Neurogene from $45.00 to $16.00 and set an "outperform" rating on the stock in a research report on Monday.April 16, 2025 | marketbeat.comJPMorgan Chase & Co. Purchases 476,418 Shares of Neurogene Inc. (NASDAQ:NGNE)JPMorgan Chase & Co. grew its holdings in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) by 10,395.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 481,001 shares of the company's stock after purchasing an additionApril 16, 2025 | marketbeat.comNeurogene price target lowered to $16 from $45 at BMO CapitalApril 14, 2025 | markets.businessinsider.comNeurogene modifie son accord et émet des bons de souscriptionApril 14, 2025 | fr.investing.comBMO réduit l’objectif de cours de Neurogene à 16$ contre 45$, maintient SurperformanceApril 14, 2025 | fr.investing.comL’action NGNE touche son plus bas niveau sur 52 semaines à 8,35$April 7, 2025 | fr.investing.com62,640 Shares in Neurogene Inc. (NASDAQ:NGNE) Bought by Blair William & Co. ILBlair William & Co. IL acquired a new stake in shares of Neurogene Inc. (NASDAQ:NGNE - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 62,640 shares of the company's stock, valued at approximately $1,432,000. Blair William & Co. IL ownedApril 4, 2025 | marketbeat.comNeurogene announces peer-reviewed publication of EXACT transgene technologyApril 3, 2025 | markets.businessinsider.comNeurogene annonce des progrès dans sa technologie de régulation de thérapie géniqueApril 2, 2025 | fr.investing.comL’action NGNE touche son plus bas niveau sur 52 semaines à 13,42$March 31, 2025 | fr.investing.comWhat is HC Wainwright's Forecast for Neurogene Q1 Earnings?Neurogene Inc. (NASDAQ:NGNE - Free Report) - Stock analysts at HC Wainwright issued their Q1 2025 earnings per share estimates for shares of Neurogene in a research note issued on Tuesday, March 25th. HC Wainwright analyst M. Kapoor forecasts that the company will post earnings of ($0.85) per shaMarch 28, 2025 | marketbeat.comQ1 Earnings Estimate for Neurogene Issued By Leerink PartnrsNeurogene Inc. (NASDAQ:NGNE - Free Report) - Analysts at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for shares of Neurogene in a research note issued to investors on Monday, March 24th. Leerink Partnrs analyst M. Foroohar expects that the company will earn ($1.12) perMarch 28, 2025 | marketbeat.comWhat is William Blair's Estimate for Neurogene Q1 Earnings?Neurogene Inc. (NASDAQ:NGNE - Free Report) - Stock analysts at William Blair issued their Q1 2025 EPS estimates for shares of Neurogene in a research report issued on Tuesday, March 25th. William Blair analyst S. Corwin expects that the company will post earnings of ($0.92) per share for the quarMarch 28, 2025 | marketbeat.comStifel maintient sa recommandation d’achat sur Neurogene avec un objectif de 46$March 27, 2025 | fr.investing.comQ1 Earnings Estimate for Neurogene Issued By William BlairNeurogene Inc. (NASDAQ:NGNE - Free Report) - William Blair issued their Q1 2026 earnings estimates for Neurogene in a note issued to investors on Tuesday, March 25th. William Blair analyst S. Corwin anticipates that the company will post earnings of ($1.18) per share for the quarter. William BlaiMarch 27, 2025 | marketbeat.comNeurogene Reports 2024 Financial Results and Advances in Rett Syndrome TrialMarch 26, 2025 | tipranks.com Get Neurogene News Delivered to You Automatically Sign up to receive the latest news and ratings for NGNE and its competitors with MarketBeat's FREE daily newsletter. Email Address NGNE Media Mentions By Week NGNE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NGNE News Sentiment▼1.401.03▲Average Medical News Sentiment NGNE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NGNE Articles This Week▼33▲NGNE Articles Average Week Get Neurogene News Delivered to You Automatically Sign up to receive the latest news and ratings for NGNE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AUPH News GYRE News MLYS News WVE News PAHC News ARDX News COLL News NTLA News RCUS News AVDL News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NGNE) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neurogene Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neurogene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NGNE Stock Free NGNE Stock Alerts